ERBB2 and triple-negative breast carcinoma: Furthermore, compared with our cohort, HR+/HER2+, HR−/HER2+ and triple-negative breast cancer were found at smaller proportions in the MSKCC33 and TCGA32 datasets, and thus, our work greatly increases the amount of available sequencing data and contributes to an improved understanding of these molecular subtypes.